Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study

BACKGROUND: Large outbreaks of Lassa fever (LF) occur annually in Nigeria. The case fatality rate among hospitalised cases is ~ 20%. The antiviral drug ribavirin along with supportive care and rehydration are the recommended treatments but must be administered early (within 6 days of symptom onset)...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:BMC Infect Dis
Main Authors: Chandra, Nastassya L., Bolt, Hikaru, Dan-Nwafor, Chioma, Ipadeola, Oladipupo, Ilori, Elsie, Namara, Geoffrey, Olayinka, Adebola T., Ukponu, Winifred, Iniobong, Akanimo, Amedu, Michael, Akano, Adejoke, Akabike, Kachikwulu O., Okhuarobo, Uwaifiokun, Fagbemi, Stephen, Sampson, Emeka, Newitt, Sophie, Verlander, Neville Q., Bausch, Daniel G., le Polain de Waroux, Olivier, Ihekweazu, Chikwe
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2021
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863257/
https://ncbi.nlm.nih.gov/pubmed/33541278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05822-4
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים